Patent · US Active

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

US9586942B2 · kind B2 · utility

0Cited by

27References

20Claims

0Family size

Assignees

Abb Vie Deutschland Gmbh & Co. KG · DE
Abb Vie Inc. · US

Inventors

Wilhelm Amberg · Ludwigshafen, DE
Frauke Pohlki · Wiesbaden, DE
Udo Lange · Ludwigshafen, DE
Ying Wang · Lake Villa, US
Jason T. Brewer · Zion, US
Anil Vasudevan · Union Grove, US
Yanbin Lao · Libertyville, US
Charles W. Hutchins · Libertyville, US
Hongyu Zhao · Libertyville, US
Huan-Qiu Li · Cambridge, US

Key dates

Filing date	Oct 17, 2014
Grant date	Mar 7, 2017
Priority date	—
Expiry date	Oct 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to aminotetraline and aminoindane derivatives of the formula (I)or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.